Greenstone, Intel AI partner to scale human-centric drug discovery (opens in new tab)

Greenstone Biosciences, Inc. and Intel Corp. announced a strategic collaboration in Palo Alto, Calif., to scale human-centric drug discovery by integrating Greenstone’s induced pluripotent stem cell biobank with Intel’s Edge AI computing and infrastructure. The partnership aims to accelerate AI-enabled drug discovery, improve drug safety assessment, and advance precision medicine by scaling data processing, storage […] The post appeared first on <a href="